BMI vs ESE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BMI

33.3
AI Score
VS
ESE Wins

ESE

37.9
AI Score

Investment Advisor Scores

BMI

33score
Recommendation
SELL

ESE

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BMI ESE Winner
Revenue 938.03M 424.60M ESE
Net Income 96.16M 57.05M ESE
Net Margin 10.3% 13.4% BMI
ROE 5.9% 8.4% BMI
ROA 4.0% 5.7% BMI
Total Assets 2.42B 998.17M ESE
Cash 73.24M 95.73M BMI
Current Ratio 1.38 2.42 BMI

Relative Price Performance (Last 90 Days)

BMI 1M: +12.5% · 3M: +18.5% ESE 1M: -12.5% · 3M: -28.9%

Current Technical Phase

BMI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 74

RSI (14): 74.0 · Price: $149.64

ESE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.0%), weak momentum, RSI 25

RSI (14): 24.8 · Price: $232.99

Fundamentals Snapshot

Metric BMI ESE
Market Cap — —
Forward P/E 30.5 25.3
Trailing P/E 30.8 45.9
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.4% 0.4%
Operating Margin 0.2% 0.1%
EPS 4.28 5.39
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ESE is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.